---
title: "SHAH MAHENDRA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/6943b064-e7ed-5a4f-8109-013155e459af
json: https://whiteintel.dev/api/public/dossier/6943b064-e7ed-5a4f-8109-013155e459af
identifier: sec:0001255449
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SHAH MAHENDRA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001255449`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/6943b064-e7ed-5a4f-8109-013155e459af  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/6943b064-e7ed-5a4f-8109-013155e459af  

## Ownership & control

### Holdings / subsidiaries

- **Verona Pharma plc** (director) — https://whiteintel.dev/entity/41379ce3-4aa7-53fc-a41d-3ba7910eb370
- **BOLT BIOTHERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/a16ad017-8d37-51da-b504-fe5209392c9c
- **IMPEL NEUROPHARMA INC** (director) — https://whiteintel.dev/entity/32a51ecc-2194-5141-922b-0b01ac58d5f7
- **SOLENO THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/41a191b5-6ff6-57e7-97aa-0f1cf6fcc9d9
- **Q32 Bio Inc.** (director) — https://whiteintel.dev/entity/08894b83-faf4-53f2-980d-374ae48ff38a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SHAH MAHENDRA**. Human view: https://whiteintel.dev/entity/6943b064-e7ed-5a4f-8109-013155e459af · Structured JSON: https://whiteintel.dev/api/public/dossier/6943b064-e7ed-5a4f-8109-013155e459af._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._